$70.9B
$849,000
0.4% of portfolio
6,216
Q3 2024
Reduced 1.11%
$0
$808,000
0.38% of portfolio
9,213
Q3 2024
Added 0.1%
$0
$776,000
0.37% of portfolio
1,471
Q2 2024
Added 0.14%
$82.2B
$769,000
0.36% of portfolio
3,941
Q1 2020
New
$124B
$736,000
0.35% of portfolio
14,233
Q1 2024
Reduced 13.09%
$71.8B
$715,000
0.34% of portfolio
4,593
Q3 2024
Reduced 0.52%
$422B
$690,000
0.33% of portfolio
1
Q1 2024
Reduced 50.0%
$494B
$668,000
0.32% of portfolio
5,700
Q3 2024
Added 0.44%
$88.6B
$655,000
0.31% of portfolio
1,037
Q3 2020
New
$175B
$590,000
0.28% of portfolio
4,879
Q1 2024
Reduced 0.77%
$83.9B
$595,000
0.28% of portfolio
2,448
Q1 2024
Added 11.88%
$232B
$570,000
0.27% of portfolio
1,102
Q1 2023
Reduced 3.08%
$1.26T
$472,000
0.22% of portfolio
825
Q2 2023
New
$60.8B
$403,000
0.19% of portfolio
1,724
Q2 2023
Added 2.13%
$25B
$374,000
0.18% of portfolio
1,952
Q1 2022
Added 30.13%
$151B
$354,000
0.17% of portfolio
4,196
Q4 2023
Reduced 32.28%
$72.7B
$350,000
0.17% of portfolio
10,146
Q2 2021
Added 200.0%
$60.1B
$367,000
0.17% of portfolio
1,480
Q1 2020
New
$0
$357,000
0.17% of portfolio
732
Q2 2024
Reduced 7.22%
$62.2B
$339,000
0.16% of portfolio
4,219
Q1 2024
Reduced 2.25%
$63.5B
$337,000
0.16% of portfolio
1,400
Q1 2020
New
$199B
$340,000
0.16% of portfolio
551
Q4 2023
New
$86.8B
$313,000
0.15% of portfolio
2,065
Q3 2024
Reduced 8.22%
$20.7B
$317,000
0.15% of portfolio
1,950
Q3 2024
Reduced 12.95%
$540B
$297,000
0.14% of portfolio
508
Q3 2024
Reduced 1.93%
$149B
$290,000
0.14% of portfolio
1,145
Q1 2024
New
$4.78B
$306,000
0.14% of portfolio
7,946
Q3 2024
Reduced 0.54%
$79.2B
$293,000
0.14% of portfolio
1,802
Q3 2024
Reduced 7.68%
$0
$271,000
0.13% of portfolio
4,306
Q4 2022
New
$78.3B
$271,000
0.13% of portfolio
577
Q1 2024
New
$153B
$283,000
0.13% of portfolio
1,371
Q4 2023
New
$96.1B
$244,000
0.12% of portfolio
2,715
Q2 2024
New
$0
$255,000
0.12% of portfolio
904
Q4 2023
Reduced 9.87%
$245B
$247,000
0.12% of portfolio
2,179
Q3 2024
Reduced 4.35%
$63.1B
$249,000
0.12% of portfolio
5,000
Q4 2023
New
$68.8B
$250,000
0.12% of portfolio
8,616
Q1 2024
Reduced 6.61%
$93.1B
$253,000
0.12% of portfolio
2,865
Q3 2024
New
$5.35B
$249,000
0.12% of portfolio
5,500
Q4 2022
New
$234B
$252,000
0.12% of portfolio
4,747
Q1 2024
Reduced 2.67%
$141B
$260,000
0.12% of portfolio
8,999
Q3 2024
New
$231B
$254,000
0.12% of portfolio
2,400
Q3 2024
New
$41.8B
$223,000
0.11% of portfolio
2,151
Q1 2024
New
$0
$241,000
0.11% of portfolio
3,717
Q2 2024
Reduced 4.08%
$35.2B
$234,000
0.11% of portfolio
740
Q3 2024
Reduced 3.9%
$47B
$230,000
0.11% of portfolio
4,469
Q2 2023
Reduced 30.92%
$34.7B
$226,000
0.11% of portfolio
1,053
Q4 2023
New
$0
$210,000
0.1% of portfolio
3,995
Q3 2024
New
$37.7B
$218,000
0.1% of portfolio
2,802
Q1 2024
Reduced 4.53%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 4.71%
Ge Healthcare Technologies I
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 1.05%